Clinical Trial Update: Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing a higher dose of ramipril to the addition of telmisartan-ramipril in hypertension with type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ramipril (ramipril)
• Telmisartan-Ramipril (Telmisartan-ramipril)

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Hypertension, Type 2 Diabetes | Phase 3 | Status: TERMINATED